Retinal guanylyl cyclase 1 (RetGC1) (RetGC1; GUCY2D (gene name))

Retinal guanylyl cyclase 1 (RetGC1) is a membrane-bound enzyme expressed in photoreceptor rod and cone cells that catalyzes the synthesis of cyclic GMP (cGMP), a critical second messenger in visual signal transduction. RetGC1 plays an essential role in promoting visual recovery during phototransduction by replenishing cGMP levels after light activation. The enzyme is tightly regulated through allosteric interactions: at low intracellular calcium levels (as occur in light-activated photoreceptors), GCAP1 bound to magnesium activates RetGC1 by stabilizing an active dimeric conformation. Conversely, at elevated calcium levels (in dark-adapted photoreceptors), calcium-bound GCAP1 and the regulatory protein RD3 inhibit the cyclase by locking it in an inactive state. Mutations in the GUCY2D gene encoding RetGC1 cause Leber congenital amaurosis type 1 (LCA1), an autosomal recessive blinding disorder that represents one of the most severe forms of inherited retinal degeneration. Understanding the structural mechanisms of RetGC1 regulation has revealed potential therapeutic targets, including small molecule inhibitors designed to prevent constitutively active GCAP1 mutants from overstimulating the cyclase.

Other names

Retinal membrane guanylate cyclase 1Retinal guanylate cyclase 1Guanylyl cyclase-1

RetGC1 is regulated through allosteric mechanisms: - Activation: Binding of Ca²⁺-free/Mg²⁺-bound guanylate cyclase-activating protein 1 (GCAP1) stabilizes RetGC1 in an active R-state conformation, stimulating cGMP synthesis - Inhibition: Binding of Ca²⁺-bound GCAP1 and/or retinal degeneration 3 protein (RD3) locks RetGC1 in an inactive T-state conformation, suppressing enzymatic activity - The enzyme exists as a dimer with two catalytic domains that assemble or disassemble the active site depending on conformational state